PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
IDXX vs. DXCM
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between IDXX and DXCM is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.4

Performance

IDXX vs. DXCM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in IDEXX Laboratories, Inc. (IDXX) and DexCom, Inc. (DXCM). The values are adjusted to include any dividend payments, if applicable.

-40.00%-30.00%-20.00%-10.00%0.00%10.00%AugustSeptemberOctoberNovemberDecember2025
-10.87%
-24.75%
IDXX
DXCM

Key characteristics

Sharpe Ratio

IDXX:

-0.69

DXCM:

-0.60

Sortino Ratio

IDXX:

-0.87

DXCM:

-0.45

Omega Ratio

IDXX:

0.89

DXCM:

0.91

Calmar Ratio

IDXX:

-0.44

DXCM:

-0.54

Martin Ratio

IDXX:

-1.09

DXCM:

-0.95

Ulcer Index

IDXX:

17.14%

DXCM:

34.29%

Daily Std Dev

IDXX:

27.05%

DXCM:

54.92%

Max Drawdown

IDXX:

-81.46%

DXCM:

-94.61%

Current Drawdown

IDXX:

-40.59%

DXCM:

-48.17%

Fundamentals

Market Cap

IDXX:

$35.10B

DXCM:

$33.14B

EPS

IDXX:

$10.15

DXCM:

$1.64

PE Ratio

IDXX:

41.31

DXCM:

51.45

PEG Ratio

IDXX:

4.41

DXCM:

1.32

Total Revenue (TTM)

IDXX:

$2.94B

DXCM:

$2.92B

Gross Profit (TTM)

IDXX:

$1.81B

DXCM:

$1.78B

EBITDA (TTM)

IDXX:

$977.28M

DXCM:

$671.70M

Returns By Period

In the year-to-date period, IDXX achieves a 1.41% return, which is significantly lower than DXCM's 8.50% return. Over the past 10 years, IDXX has underperformed DXCM with an annualized return of 17.57%, while DXCM has yielded a comparatively higher 19.34% annualized return.


IDXX

YTD

1.41%

1M

1.70%

6M

-11.79%

1Y

-19.96%

5Y*

7.86%

10Y*

17.57%

DXCM

YTD

8.50%

1M

5.42%

6M

-24.42%

1Y

-33.71%

5Y*

7.48%

10Y*

19.34%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

IDXX vs. DXCM — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IDXX
The Risk-Adjusted Performance Rank of IDXX is 1515
Overall Rank
The Sharpe Ratio Rank of IDXX is 1212
Sharpe Ratio Rank
The Sortino Ratio Rank of IDXX is 1313
Sortino Ratio Rank
The Omega Ratio Rank of IDXX is 1313
Omega Ratio Rank
The Calmar Ratio Rank of IDXX is 1919
Calmar Ratio Rank
The Martin Ratio Rank of IDXX is 1919
Martin Ratio Rank

DXCM
The Risk-Adjusted Performance Rank of DXCM is 1818
Overall Rank
The Sharpe Ratio Rank of DXCM is 1616
Sharpe Ratio Rank
The Sortino Ratio Rank of DXCM is 2121
Sortino Ratio Rank
The Omega Ratio Rank of DXCM is 1616
Omega Ratio Rank
The Calmar Ratio Rank of DXCM is 1515
Calmar Ratio Rank
The Martin Ratio Rank of DXCM is 2424
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

IDXX vs. DXCM - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for IDEXX Laboratories, Inc. (IDXX) and DexCom, Inc. (DXCM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for IDXX, currently valued at -0.69, compared to the broader market-2.000.002.004.00-0.69-0.60
The chart of Sortino ratio for IDXX, currently valued at -0.87, compared to the broader market-4.00-2.000.002.004.00-0.87-0.45
The chart of Omega ratio for IDXX, currently valued at 0.89, compared to the broader market0.501.001.502.000.890.91
The chart of Calmar ratio for IDXX, currently valued at -0.44, compared to the broader market0.002.004.006.00-0.44-0.54
The chart of Martin ratio for IDXX, currently valued at -1.09, compared to the broader market-10.000.0010.0020.0030.00-1.09-0.95
IDXX
DXCM

The current IDXX Sharpe Ratio is -0.69, which is comparable to the DXCM Sharpe Ratio of -0.60. The chart below compares the historical Sharpe Ratios of IDXX and DXCM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.50AugustSeptemberOctoberNovemberDecember2025
-0.69
-0.60
IDXX
DXCM

Dividends

IDXX vs. DXCM - Dividend Comparison

Neither IDXX nor DXCM has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

IDXX vs. DXCM - Drawdown Comparison

The maximum IDXX drawdown since its inception was -81.46%, smaller than the maximum DXCM drawdown of -94.61%. Use the drawdown chart below to compare losses from any high point for IDXX and DXCM. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%AugustSeptemberOctoberNovemberDecember2025
-40.59%
-48.17%
IDXX
DXCM

Volatility

IDXX vs. DXCM - Volatility Comparison

The current volatility for IDEXX Laboratories, Inc. (IDXX) is 7.57%, while DexCom, Inc. (DXCM) has a volatility of 10.83%. This indicates that IDXX experiences smaller price fluctuations and is considered to be less risky than DXCM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%AugustSeptemberOctoberNovemberDecember2025
7.57%
10.83%
IDXX
DXCM

Financials

IDXX vs. DXCM - Financials Comparison

This section allows you to compare key financial metrics between IDEXX Laboratories, Inc. and DexCom, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab